Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
for Secondary Immune Deficiency
Sites in Morristown, Hackensack +15 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT07648264·Phase 3·Recruiting·Listed Jun 2026